Navigation Links
AMDL Signs 100 Strategic Cooperation Agreements in China for Its JPGreen Clinics; Gross Sales Per Each Location Could Exceed $400,000
Date:1/25/2008

TUSTIN, Calif., Jan. 25 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), headquartered in Tustin, California, with operations in Shenzhen, Jiangxi, and Jilin China, through its wholly owned subsidiary Jade Pharmaceutical Inc., is an international biopharma company that, together with Jade, engages in the development, manufacture and marketing of proprietary pharmaceutical, health care and diagnostic products. It today announced that more than 100 individual owners of existing health spa centers in China have signed strategic cooperation agreements with JJB, a Jade subsidiary.

The agreements allow JJB to re-brand the locations as JPGreen anti-aging & spa clinics. JJB is the exclusive supplier of its anti-aging product "Goodnak." The agreements follow a January meeting at the Beijing Diaoyutai State Guesthouse that attracted approximately 200 health spa center owners who want to cooperate with JJB in order to expand the JPGreen centers.

Frank Zhang, Managing Director of Jade, stated that "these new strategic cooperation agreements will allow JJB to increase the sales of the expanding family of Goodnak anti-aging injections, capsules, creams and spray products into the China market during 2008. Each new clinic location is anticipated to annually contribute $400,000 to $700,000 in gross sales per location."

Mr. Gary Dreher, CEO of AMDL noted that "these new regional Chinese strategic cooperation relationships are significant achievements and improves Jade's ability to grow its sales in 2008 and beyond."

About Jade Pharmaceutical: Jade has access to the fastest growing pharmaceutical and consumer market in the world: China. AMDL, through its subsidiaries, Jade currently manufactures large volume injection fluids, tablets and other related products, holding licenses for 133 products. It also manufactures 107 generic, over the counter and supplemental pharmaceutical products under certified Chinese Good Manufacturing Practice ('CGMP') st
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
2. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
3. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
4. Monsanto Company Signs Share Subscription Agreement With Devgen
5. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
6. Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company
7. Spanish Research Consortium Signs Four-Year Renewal Deal for ISI Web of Knowledge
8. Assay Designs(TM) Announces Additions to the Leadership Team
9. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
10. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
11. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
(Date:11/5/2009)...ember 5, 2009 at 4:30 p.m. Eastern Time , BOT...l/ - OncoGenex Pharmaceuticals, Inc. ("OncoGenex" ...unaudited financial results for the third quarter ...wed the Company,s highlights for the third quarter... reflect the operations of OncoGenex Technologies ...
(Date:11/5/2009)... Senomyx, Inc. (Nasdaq: ...te receptor-based technologies to discover novel f...edient supply industries, today provided a corpora...hird quarter ended September 30, 2009. Revenues w...mpared to $4.0 million for the third quarter of 20...
(Date:11/5/2009)...y and vision correction experts listed in the Trus...d at the recently concluded American Academy of Op...isco, California. Dr. Stephen Brint, MD, Dr. Frede...r. Peter Rapoza, MD, Dr. Michael Raizman, MD, Dr. ...dward Manche, MD, and Dr. Parag Majmudar, MD, all ...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 2Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 3Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 4Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 5Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 6Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 7Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 8Leading Vision Correction Experts in Trusted LASIK Surgeons Directory Educate Fellow Doctors at AAO Annual Meeting 9
...alif., Sept. 18 InterMune, Inc.,(Nasdaq: ITMN ) ... market,and other conditions, 3,000,000 shares of ...g. The Company expects to grant the underwriters,a...,000 shares of common,stock in connection with the...be sold by InterMune. Goldman, Sachs & Co. is act...
...alif., Sept. 18 Dynavax,Technologies Corporation ...Vice President and Chief Financial Officer, will p...Global Life Sciences Conference in New York, New,Y...n Daylight Savings Time,(6:30 a.m. PDST). The pres...o broadcast and the subsequent archived audio,reco...
...as, Sept. 18 Luminex Corporation,(Nasdaq: LMNX )...he fourth,annual America,s Growth Capital Emerging...in Boston. The investor presentation by Patrick J... and Harriss T. Currie, chief financial officer, w...eptember 20, 2007. The,presentation will be webcas...
Other Biology Technology:InterMune Announces Proposed Public Offering of Common Stock 2Dynavax to Present at UBS 2007 Global Life Sciences Conference 2Luminex Corporation to Present at America's Growth Capital Emerging Growth Conference 2
(Date:11/4/2009)... What,s the cost of saving a teena...ath resulting from prescription medication abuse, ..., however, may be unaware that the lock-boxes they...the ticking timebomb of prescription drugs. That,s...ity medical supplies, has formed an exclusive part...
(Date:11/4/2009)...ntists at the University of North Carolina at Chap...alifornia, San Francisco have developed and experi...diseases for existing drugs. , The researchers d...similar the structures of all known drugs are to t...s ligands -- of disease targets within the cell. I...
(Date:11/3/2009)...ember 4, 2009) For more than 25 years, all attemp...mbus gigas ) have been unsuccessfuluntil now. For ...niques to produce beaded (nucleated) and non-beade...eveloped by scientists from Florida Atlantic Unive...I). With less than two years of research and exper...
Breaking Biology News(10 mins):MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 1Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 2Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 3Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 4Anadys Pharmaceuticals Inc Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598 12473 5Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 1Jefferson researchers identify critical marker of response to gemcitabine in pancreatic cancer 47918 2Scientists discover new genetic immune disorder in children 8716 1Scientists discover new genetic immune disorder in children 8716 2Scientists discover new genetic immune disorder in children 8716 3
... have discovered the first microRNAs tiny bits of...of 10 major degenerative muscular disorders, openi... understanding of these debilitating, poorly under...e published online this week by the Proceedings of... Eisenberg, PhD, of the Program in Genomics at Chi...
... October 17, 2007A late-breaking symposium, Colony...tus, Potential Causes, and Preventive Measures, ha...f the Entomological Society of America (ESA), to b... headed by entomologists Diana Cox-Foster (Penn St...xplore possible factors that may have caused honey...
...n, DC. Ocean Conservancy Scientist, Wallace J. Nic...rcher Hoyt Peckham found surprising results in a r...at Nichols and Peckham conducted over the course o...tober 17 in the online, open-access journal PLoS O... operations are a greater threat to the survival o...
Other Biology News:Massive microRNA scan uncovers leads to treating muscle degeneration 2Research shows loggerhead sea turtles threatened by small-scale fishing operations 2
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Rabbit Anti-Human Naked1 Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Phosphothreonine-X-Phosphotyrosine Polyclonal Antibody, Horseradish Peroxidase Conjugated from Abcam
Rabbit Anti-Human ADAMTS-4, disintegrin-like domain Antibody, Unconjugated from CHEMICON
Biology Products: